Literature DB >> 15678128

Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.

Atsushi Saito1, Takeshi Hayashi, Shuzo Okuno, Tatsuro Nishi, Pak H Chan.   

Abstract

The tumor suppressor gene p53 plays an important role in the regulation of apoptosis through transcriptional activation of cell cycle control. Degradation of p53 hinders its role in apoptosis regulation. Recent studies have shown that MDM2-mediated ubiquitylation and the ubiquitin-proteasome system are critical regulating systems of p53 ubiquitylation. However, the mechanism regulating p53-mediated neuronal apoptosis after cerebral ischemia remains unknown. We examined the MDM2 pathway and the ubiquitin-proteasome system using a transient focal cerebral ischemia (tFCI) model and analyzed the interaction between p53 regulation and superoxide using copper/zinc superoxide dismutase (SOD1) transgenic mice after tFCI. p53 degradation and ubiquitylation were detected after tFCI. The accumulation of ubiquitylated p53 was inhibited and p53 degradation was facilitated by SOD1. Nuclear translocation and MDM2/Akt interaction were detected after tFCI and were inhibited by phosphatidylinositol 3-kinase inhibition and promoted by SOD1. Cytosolic translocation of the p53/MDM2 complex was detected after tFCI and was promoted by SOD1. Moreover, accumulation of multiubiquitin chains and direct oxidative injury to a proteasome were detected and inhibited by SOD1 after tFCI. These results suggest that SOD1 promotes the MDM2 pathway and the ubiquitin-proteasome system after tFCI and that production of reactive oxygen species after tFCI prevents p53 degradation by inhibiting both systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15678128     DOI: 10.1038/sj.jcbfm.9600028

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  28 in total

Review 1.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.

Authors:  Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

Review 2.  p53-mediated neuronal cell death in ischemic brain injury.

Authors:  Li-Zhi Hong; Xiao-Yuan Zhao; Hui-Ling Zhang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 3.  Is Cytoplasmic PTEN a Specific Target for Neuronal Survival?

Authors:  Anand Krishnan; Douglas W Zochodne
Journal:  Mol Neurobiol       Date:  2014-11-09       Impact factor: 5.590

4.  The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib.

Authors:  Azmi Yerlikaya; Emrah Okur; Engin Ulukaya
Journal:  Tumour Biol       Date:  2012-04-04

Review 5.  Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury.

Authors:  Karin Hochrainer
Journal:  Transl Stroke Res       Date:  2017-08-25       Impact factor: 6.829

Review 6.  Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection.

Authors:  Hai Chen; Hideyuki Yoshioka; Gab Seok Kim; Joo Eun Jung; Nobuya Okami; Hiroyuki Sakata; Carolina M Maier; Purnima Narasimhan; Christina E Goeders; Pak H Chan
Journal:  Antioxid Redox Signal       Date:  2011-01-09       Impact factor: 8.401

7.  Reperfusion rather than ischemia drives the formation of ubiquitin aggregates after middle cerebral artery occlusion.

Authors:  Karin Hochrainer; Katherine Jackman; Josef Anrather; Costantino Iadecola
Journal:  Stroke       Date:  2012-06-14       Impact factor: 7.914

8.  Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons.

Authors:  Takuma Uo; Yoshito Kinoshita; Richard S Morrison
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  Local cooling provides muscle flaps protection from ischemia-reperfusion injury in the event of venous occlusion during the early reperfusion period.

Authors:  Ryan S Diederich; Arian Mowlavi; Garth Meldrum; Brad Medling; Reuben A Bueno; Michael W Neumeister
Journal:  Hand (N Y)       Date:  2008-09-24

10.  CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia.

Authors:  Gab Seok Kim; Joo Eun Jung; Kuniyasu Niizuma; Pak H Chan
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.